Annual Working Capital
$83.96 M
-$34.62 M-29.20%
December 31, 2023
Summary
- As of March 1, 2025, LVTX annual working capital is $83.96 million, with the most recent change of -$34.62 million (-29.20%) on December 31, 2023.
- During the last 3 years, LVTX annual working capital has risen by +$73.07 million (+671.16%).
- LVTX annual working capital is now -32.97% below its all-time high of $125.26 million, reached on December 31, 2021.
Performance
LVTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$66.34 M
-$9.72 M-12.78%
September 30, 2024
Summary
- As of March 1, 2025, LVTX quarterly working capital is $66.34 million, with the most recent change of -$9.72 million (-12.78%) on September 30, 2024.
- Over the past year, LVTX quarterly working capital has dropped by -$20.83 million (-23.89%).
- LVTX quarterly working capital is now -54.16% below its all-time high of $144.73 million, reached on June 30, 2021.
Performance
LVTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LVTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.2% | -23.9% |
| 3 y3 years | +671.2% | -23.9% |
| 5 y5 years | +1255.0% | -23.9% |
LVTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.0% | at low | -48.9% | at low |
| 5 y | 5-year | -33.0% | +1255.0% | -54.2% | +509.3% |
| alltime | all time | -33.0% | +1255.0% | -54.2% | +509.3% |
LAVA Therapeutics NV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $66.34 M(-12.8%) |
| Jun 2024 | - | $76.06 M(-9.1%) |
| Mar 2024 | - | $83.64 M(-0.4%) |
| Dec 2023 | $83.96 M(-29.2%) | $83.96 M(-3.7%) |
| Sep 2023 | - | $87.16 M(-9.4%) |
| Jun 2023 | - | $96.19 M(-10.1%) |
| Mar 2023 | - | $107.04 M(-9.7%) |
| Dec 2022 | $118.58 M | $118.58 M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $129.74 M(+35.1%) |
| Jun 2022 | - | $96.06 M(-12.9%) |
| Mar 2022 | - | $110.35 M(-11.9%) |
| Dec 2021 | $125.26 M(+1050.5%) | $125.26 M(-7.5%) |
| Sep 2021 | - | $135.40 M(-6.4%) |
| Jun 2021 | - | $144.73 M(+3.2%) |
| Mar 2021 | - | $140.29 M(+1188.6%) |
| Dec 2020 | $10.89 M(+75.7%) | $10.89 M |
| Dec 2019 | $6.20 M | - |
FAQ
- What is LAVA Therapeutics NV annual working capital?
- What is the all time high annual working capital for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual working capital year-on-year change?
- What is LAVA Therapeutics NV quarterly working capital?
- What is the all time high quarterly working capital for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly working capital year-on-year change?
What is LAVA Therapeutics NV annual working capital?
The current annual working capital of LVTX is $83.96 M
What is the all time high annual working capital for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual working capital is $125.26 M
What is LAVA Therapeutics NV annual working capital year-on-year change?
Over the past year, LVTX annual working capital has changed by -$34.62 M (-29.20%)
What is LAVA Therapeutics NV quarterly working capital?
The current quarterly working capital of LVTX is $66.34 M
What is the all time high quarterly working capital for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly working capital is $144.73 M
What is LAVA Therapeutics NV quarterly working capital year-on-year change?
Over the past year, LVTX quarterly working capital has changed by -$20.83 M (-23.89%)